Morphic Therapeutic

Morphic Therapeutic
Last activity: 05.03.2024
Categories: MedtechLEDFamilyDrugDevelopmentCommerce
Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn's disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention. Despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.
Location: United States, Massachusetts, Waltham
Employees: 51-200
Total raised: $131.5M
Founded date: 2015

Investors 5

Funding Rounds 2

25.09.2018Series B$80M-
30.06.2016Series A$51.5MSR One

Mentions in press and media 14

05.03.2024Morphic to Participate in March Investor Conferences-globenewsw...
03.05.2023Morphic Therapeutic Announces Pricing of $240.0 Million Publ...-globenewsw...
18.10.2018Morphic partners with investor AbbVie on integrin inhibitor ...Last month, Morphic closed an $80 million Series B financing – in which AbbVie Ventures participated...medcitynew...
26.09.2018Term Sheet — Wednesday, September 26THE UNRAVELING Good morning, Term Sheet readers. Paid Content Securing the enterprise without
26.09.2018Morphic Therapeutic Announces $80M WALTHAM, MA, Morphic Therapeutic announced today that it has completed a $80 million Series B fina...vcnewsdail...
26.09.2018Morphic Therapeutic Raises $80M in Series B FinancingMorphic Therapeutic, a Waltham, Mass.-based biotechnology company developing a new generation of
25.09.2018Morphic raises $80M in Series B round to fund oral integrin ...“With compelling preclinical data across a number of programs, we are accelerating our advance into ...medcitynew...
30.06.2016Morphic Therapeutic Nets $51.5M WALTHAM, MA, Morphic Therapeutic, a biotechnology company developing a new generation of oral inte...vcnewsdail...
30.06.2016Biotechnology Company Morphic Therapeutic Closes $51.5M Seri...Morphic Therapeutic, a Waltham, MA-based biotechnology company developing a new generation of oral
30.06.2016Morphic Therapeutic Raises $51.5M Series A Co-Led by SR One ...WALTHAM, Mass.--(BUSINESS WIRE)--Morphic Therapeutic, a biotechnology company developing a new gener...citybizlis...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In